USClinicalTrials.gov【Trial record】
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Phase 1/2RecruitingSource updated: Oct 1, 2026
Cancer types
Esophageal Cancer
Squamous cell and adenocarcinoma. 86 official records currently indexed across three regions.
Trial records retrieved live from the ClinicalTrials.gov public API.
Showing 86 of 86
Highlight terms:
Build a discussion list0 selected
Select the public official records you want to take to your appointment, then generate a list. Nothing is ranked or recommended — the list only reproduces titles and links.
Not signed in — up to 5 records per list. Sign in for higher free limits, or see Pro for more exports.
USEUCNOTHERClinicalTrials.gov【Trial record】
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 2RecruitingSource updated: Oct 1, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Phase 1RecruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Phase 2/3RecruitingSource updated: Oct 1, 2026
EUClinicalTrials.gov【Trial record】
HTL0039732 in Participants With Advanced Solid Tumours
Phase 1/2RecruitingSource updated: Oct 1, 2026
USEUOTHERClinicalTrials.gov【Trial record】
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Phase 1Active, not recruitingSource updated: Oct 1, 2026
USOTHERClinicalTrials.gov【Trial record】
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Phase 2Active, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
Testing the Addition of the Anti-cancer Viral Therapy Telomelysin™ to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery
Phase 1Active, not recruitingSource updated: Oct 1, 2026
USClinicalTrials.gov【Trial record】
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Phase 1RecruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Phase 1RecruitingSource updated: Sep 30, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Phase 2/3RecruitingSource updated: Sep 30, 2026
EUClinicalTrials.gov【Trial record】
Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)
Phase 2Active, not recruitingSource updated: Sep 30, 2026
USClinicalTrials.gov【Trial record】
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Phase 1RecruitingSource updated: Sep 29, 2026
USEUOTHERClinicalTrials.gov【Trial record】
A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies
Phase 2Active, not recruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
DBC-664 in Adult Patients With Solid Tumors
Phase 1RecruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma
Enrolling by invitationSource updated: Sep 29, 2026
USCNOTHERClinicalTrials.gov【Trial record】
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
Phase 1Active, not recruitingSource updated: Sep 29, 2026
USClinicalTrials.gov【Trial record】
Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma
Phase 2RecruitingSource updated: Sep 29, 2026
OTHERClinicalTrials.gov【Trial record】
A Study Investigating Alternate Schedules of Tislelizumab Plus Chemotherapy in Japanese Patients With First-line Advanced ESCC
Phase 2RecruitingSource updated: Sep 28, 2026
USClinicalTrials.gov【Trial record】
Lucid Registry Study
RecruitingSource updated: Sep 28, 2026
USEUOTHERClinicalTrials.gov【Trial record】
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Phase 1RecruitingSource updated: Sep 28, 2026
CNClinicalTrials.gov【Trial record】
Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer
Phase 3RecruitingSource updated: Sep 28, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Phase 2/3RecruitingSource updated: Sep 28, 2026
CNClinicalTrials.gov【Trial record】
The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy
RecruitingSource updated: Sep 28, 2026
USClinicalTrials.gov【Trial record】
DESTINY-PANTUMOUR04
RecruitingSource updated: Sep 25, 2026
USEUCNOTHERClinicalTrials.gov【Trial record】
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
Phase 1/2RecruitingSource updated: Sep 25, 2026
USOTHERClinicalTrials.gov【Trial record】
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1RecruitingSource updated: Sep 24, 2026
USClinicalTrials.gov【Trial record】
A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
Phase 2RecruitingSource updated: Sep 24, 2026
EUCNOTHERClinicalTrials.gov【Trial record】
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
Phase 3Active, not recruitingSource updated: Sep 24, 2026
USClinicalTrials.gov【Trial record】
Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation Therapy
Active, not recruitingSource updated: Sep 24, 2026
USClinicalTrials.gov【Trial record】
Pan-tumor MRD Study
RecruitingSource updated: Sep 24, 2026
USClinicalTrials.gov【Trial record】
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Phase 1/2RecruitingSource updated: Sep 24, 2026
USOTHERClinicalTrials.gov【Trial record】
A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Phase 2Active, not recruitingSource updated: Sep 23, 2026
CNClinicalTrials.gov【Trial record】
Cola Ingestion for Esophageal Bolus Impaction
Not applicableActive, not recruitingSource updated: Sep 23, 2026
USClinicalTrials.gov【Trial record】
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
RecruitingSource updated: Sep 23, 2026
USClinicalTrials.gov【Trial record】
PhII Study of Toripalimab Followed by Definitive CRT & Adjuvant Toripalimab in Locally Advanced ESCC
Phase 2Not yet recruitingSource updated: Sep 23, 2026
USClinicalTrials.gov【Trial record】
sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)
Phase 2RecruitingSource updated: Sep 23, 2026
OTHERClinicalTrials.gov【Trial record】
Advanced Endo-therapeutic Procedure : Registry-based Observational Study
RecruitingSource updated: Aug 11, 2026
OTHERClinicalTrials.gov【Trial record】
AI-Driven Digital Twin and Drug Simulation for Esophageal Cancer
Not yet recruitingSource updated: Aug 11, 2026
USClinicalTrials.gov【Trial record】
ALDH2 Genetic Testing in East Asian Community
Not applicableNot yet recruitingSource updated: Aug 11, 2026
OTHERClinicalTrials.gov【Trial record】
Clinical Application of an AI-based Dissection Trajectory Prediction System (ADTPS) in Endoscopic Submucosal Dissection
Not applicableNot yet recruitingSource updated: Aug 11, 2026
CNClinicalTrials.gov【Trial record】
Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma
Not applicableRecruitingSource updated: Aug 11, 2026
USClinicalTrials.gov【Trial record】
Obeticholic Acid for Prevention in Barrett's Esophagus
Phase 2RecruitingSource updated: Aug 11, 2026
USClinicalTrials.gov【Trial record】
Ursodeoxycholic Acid in Barrett's Endotherapy
Not yet recruitingSource updated: Aug 11, 2026
USClinicalTrials.gov【Trial record】
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
RecruitingSource updated: Aug 10, 2026
OTHERClinicalTrials.gov【Trial record】
A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation
Phase 1/2Not yet recruitingSource updated: Aug 7, 2026
CNClinicalTrials.gov【Trial record】
Neoadjuvant Chemoradiotherapy Combined With CTLA-4 Monoclonal Antibody Plus PD-1 Monoclonal Antibody for Locally Advanced Esophageal Cancer
Phase 2RecruitingSource updated: Aug 7, 2026
USClinicalTrials.gov【Trial record】
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Phase 1RecruitingSource updated: Aug 6, 2026
USClinicalTrials.gov【Trial record】
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Phase 1RecruitingSource updated: Aug 6, 2026
USClinicalTrials.gov【Trial record】
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Phase 1RecruitingSource updated: Aug 6, 2026
USClinicalTrials.gov【Trial record】
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1Active, not recruitingSource updated: Aug 6, 2026
USClinicalTrials.gov【Trial record】
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Phase 1/2RecruitingSource updated: Aug 6, 2026
CNClinicalTrials.gov【Trial record】
The Impact of Surgical Treatment on Survival in Localized Small Cell Esophageal Cancer
RecruitingSource updated: Aug 6, 2026
USClinicalTrials.gov【Trial record】
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Phase 1RecruitingSource updated: Aug 5, 2026
USClinicalTrials.gov【Trial record】
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Phase 1RecruitingSource updated: Aug 5, 2026
OTHERClinicalTrials.gov【Trial record】
AB122 Platform Study
Phase 1RecruitingSource updated: Aug 5, 2026
USClinicalTrials.gov【Trial record】
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingSource updated: Aug 5, 2026
USClinicalTrials.gov【Trial record】
Distance-Based Exercise to Preserve Function and Prevent Disability
Not applicableRecruitingSource updated: Aug 5, 2026
USClinicalTrials.gov【Trial record】
Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors
Phase 1Active, not recruitingSource updated: Aug 5, 2026
USClinicalTrials.gov【Trial record】
IDOV-Immune for Advanced Solid Tumors
Phase 1RecruitingSource updated: Aug 5, 2026
USClinicalTrials.gov【Trial record】
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Phase 3RecruitingSource updated: Aug 5, 2026
CNClinicalTrials.gov【Trial record】
Perioperative Surufatinib Plus Sintilimab Combined With Chemotherapy in Gastric/Gastroesophageal Junction Adenocarcinoma
Phase 2Active, not recruitingSource updated: Aug 5, 2026
EUClinicalTrials.gov【Trial record】
REcovery After Cancer Application
Not applicableNot yet recruitingSource updated: Aug 5, 2026
USClinicalTrials.gov【Trial record】
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Not applicableRecruitingSource updated: Aug 5, 2026
CNCDE【Guideline / public regulatory information】
CDE 临床试验默示许可 — clinical trial implied licence notices
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 优先审评公示 — priority review listings
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 受理品种信息 — applications accepted for review
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 指导原则 — published technical guidance documents
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 突破性治疗公示 — breakthrough therapy designation notices
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
CDE 附条件批准品种 — conditionally approved products list
Index verified: Aug 16, 2026
CNChiCTR【Guideline / public regulatory information】
ChiCTR — Chinese Clinical Trial Registry, public search
Index verified: Aug 16, 2026
EUCTIS【Guideline / public regulatory information】
CTIS public register — search clinical trials authorised in the EU/EEA
Index verified: Aug 16, 2026
EUEMA【Guideline / public regulatory information】
EMA — CHMP meeting highlights and opinions on new medicines
Index verified: Aug 16, 2026
EUEMA【Guideline / public regulatory information】
EMA — medicines for human use currently under evaluation (monthly CHMP list)
Index verified: Aug 16, 2026
EUEMA【Guideline / public regulatory information】
EMA — searchable database of authorised medicines in the EU
Index verified: Aug 16, 2026
EUESMO【Guideline / public regulatory information】
ESMO Clinical Practice Guidelines — gastrointestinal cancers
Index verified: Aug 16, 2026
EUESMO【Guideline / public regulatory information】
ESMO Clinical Practice Guidelines — public index by tumour type
Index verified: Aug 16, 2026
EUESMO【Guideline / public regulatory information】
ESMO Clinical Practice Guidelines — supportive and palliative care section
Index verified: Aug 16, 2026
USFDA【Guideline / public regulatory information】
FDA — expanded access (compassionate use) information for patients
Index verified: Aug 16, 2026
USFDA【Guideline / public regulatory information】
FDA — oncology (cancer) / hematologic malignancies approval notifications
Index verified: Aug 16, 2026
USFDA【Guideline / public regulatory information】
FDA — ongoing accelerated approvals for oncology indications
Index verified: Aug 16, 2026
USNCCN【Guideline / public regulatory information】
NCCN Guidelines — palliative care category listing
Index verified: Aug 16, 2026
USNCCN【Guideline / public regulatory information】
NCCN Guidelines — public index by cancer type (free registration)
Index verified: Aug 16, 2026
USNCCN【Guideline / public regulatory information】
NCCN Guidelines for Patients — plain-language versions
Index verified: Aug 16, 2026
CNNMPA【Guideline / public regulatory information】
NMPA 药品 — national drug approval announcements
Index verified: Aug 16, 2026
CNCDE【Guideline / public regulatory information】
药物临床试验登记与信息公示平台 — national registry of drug trials conducted in China
Index verified: Aug 16, 2026